The Society of Nuclear Medicine & Molecular Imaging released new recommendations for performing these studies during the pandemic.
New guidance from the Society of Nuclear Medicine & Molecular Imaging (SNMMI) has been released to guide providers to safely perform ventilation and perfusion lung scans during the continuing COVID-19 outbreak.
Initial guidance from SNMMI released at the advent of the outbreak instructed providers to review the policies of their local healthcare facilities before conducting these exams, as well as confirm the patient’s COVID-19 status. The organization has now released updated guidance that reflects how the virus has continued to morph.
“The goal of this updated statement is to recognize that in some regions and clinical situations, a ventilation study may be felt to be clinically necessary to help diagnose lung disease, including vascular and airway disease,” SNMMI said in a Sept. 3 statement. “In these settings, performance of ventilation studies may be considered, with local and institutional COVID-19 policies and procedures for aerosol-generating and non-aerosolizing procedures serving as the primary source of guidance.”
In its statement, the organization outlined six considerations for providers before they conduct these exams:
Study: AI Bolsters Sensitivity for Pneumothorax on CXR and Significantly Reduces Reporting Time
October 30th 2024For clinically actionable pneumothorax, an artificial intelligence algorithm demonstrated a 93 percent AUC and a 96 percent specificity rate in a study involving chest X-rays from over 27,000 adults.
Comparative Study Evaluates AI Products for Detecting Tuberculosis on Chest X-Rays
August 9th 2024At a 90 percent threshold for sensitivity, Lunit’s Insight CXR and the Nexus CXR software from Nexus demonstrated the highest specificity rates for tuberculosis (TB) detection in a patient population with a high prevalence of TB and HIV.